Pinnacle Associates’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
WA
Pinnacle Associates's MEDP Position: Q2 2026 in Review
Pinnacle Associates reduced its Medpace (MEDP) stake by 27% in Q2 2026, selling an estimated $78.9K and leaving 469 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #865.
Pinnacle Associates first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $593K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Pinnacle Associates held 469 shares of Medpace worth $248K as of Q2 2026.
- Pinnacle Associates sold 171 Medpace shares in Q2 2026, an estimated $78.9K.
- Medpace made up ﹤0.01% of Pinnacle Associates's portfolio in Q2 2026, its #865 holding.
- Pinnacle Associates first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
- Pinnacle Associates's Medpace position peaked at $593K in Q4 2025.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.